Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Research material data sheetCAS Number: 307297-39-8Molecular Formula: C14H22N4O9Molecular Weight: 390.35 g/molPurity: 99%Physical Form: lyophilized powderStorage: lyophilized form at -20 C, up to 24 months
Over 70% of the U.S
Other contributing factors include: Antibiotic use : Concurrent antibiotic therapy for unrelated infections disrupts normal vaginal flora, allowing Candida overgrowth Hormonal factors : Hormonal fluctuations may affect vaginal pH and microbiome composition Hygiene practices : Changes in exercise routines may affect personal hygiene Vulvovaginal candidiasis should be distinguished from cutaneous candidiasis (fungal skin infections), which can occur in skin folds and may be influenced by factors such as increased sweating or prolonged moisture exposure
Participants were randomly assigned, 1:1:1, to once-weekly combination cagrilintide and semaglutide 2.4 mg, once-weekly semaglutide 2.4 mg plus placebo or once-weekly cagrilintide 2.4 mg plus placebo
US$ 27.48
US$ 26.16
US$ 25.09
US$ 27.58
US$ 28.99
US$ 29.40
US$ 24.32
US$ 29.34
US$ 22.44
US$ 21.82
.webp)
US$ 23.23
US$ 20.60
US$ 28.19
